CVS Health Confirms FY23 Adj. EPS Outlook - Update

RTTNews | 473 दिनों पहले
Stocktwits
CVS Health Confirms FY23 Adj. EPS Outlook - Update

(RTTNews) - While reporting financial results for the second quarter on Wednesday, CVS Health (CVS) on Thursday lowered its earnings guidance for the full-year 2023, while confirming annual adjusted earnings outlook.

For fiscal 2023, the company now projects earnings in a range of $6.53 to $6.75 per share and adjusted earnings in a range of $8.50 to $8.70 per share.

Previously, the company expected earnings in the range of $6.90 to $7.12 per share and adjusted earnings in a range of $8.50 to $8.70 per share.

On average, 27 analysts polled by Thomson Reuters expect the company to report earnings of $8.59 per share for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

टैग: CVS
Stocktwits
read more
CVS Health Reportedly Mulls Breakup, To Cut 2,900 Jobs

CVS Health Reportedly Mulls Breakup, To Cut 2,900 Jobs

CVS Health Corp. is conducting a strategic review of options including a possible breakup amid issues from its drugstore chain and Aetna health insurance arm, reports said citing person familiar with the matter. The company also plans to reduce its workforce by less than 1 percent, which would affect around 2,900 employees, as part of its cost-cutting efforts.
RTTNews | 46 दिनों पहले
CVS Offers Updated 2024-2025 COVID-19 And Flu Vaccines

CVS Offers Updated 2024-2025 COVID-19 And Flu Vaccines

CVS Health Corp. announced Wednesday the availability of updated 2024-2025 COVID-19 vaccines and flu vaccines at CVS Pharmacy and MinuteClinic locations across the United States. The U.S. Food and Drug Administration recently approved and granted emergency use authorization or EUA for updated Covid vaccines (2024-2025 formula) from Pfizer Inc. and ModernaTX Inc. for use against currently...
RTTNews | 81 दिनों पहले
CVS Health Slashes FY24 Outlook; Stock Down 11% - Update

CVS Health Slashes FY24 Outlook; Stock Down 11% - Update

While reporting financial results for the first quarter on Wednesday, CVS Health (CVS) slashed its earnings and adjusted earnings guidance for the full-year 2024, reflecting the potential for continued elevated medical cost trends in the remainder of 2024.
RTTNews | 200 दिनों पहले
P&G Recalls 8.2 Mln Defective Laundry Detergent Packets

P&G Recalls 8.2 Mln Defective Laundry Detergent Packets

Consumer goods giant Procter & Gamble Co. has called back around 8.2 million defective bags of Tide, Gain, Ace and Ariel laundry detergent packets distributed in the United States citing risk of serious injury, the U.S. Consumer Product Safety Commission announced. In addition, about 56,741 were sold in Canada. According to the agency, the outer packaging meant to prevent access to the contents...
RTTNews | 223 दिनों पहले
Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Walgreens, CVS To Sell Abortion Pill Mifepristone Starting In March

Pharmacy majors Walgreens Boot Alliance Inc. and CVS Health Corp. will start selling abortion pill mifepristone this month at stores in several states where it is legal. Both companies have received certification from the U.S. Food and Drug Administration to dispense the pill at their retail pharmacies.
RTTNews | 258 दिनों पहले
CVS Health Lowers FY24 Outlook - Update

CVS Health Lowers FY24 Outlook - Update

While reporting financial results for the fourth quarter on Wednesday, CVS Health (CVS) lowered its earnings and adjusted earnings guidance for the full-year 2024.
RTTNews | 284 दिनों पहले
CVS Health Confirms Tom Cowhey As New CFO

CVS Health Confirms Tom Cowhey As New CFO

CVS Health (CVS) announced Friday that Senior Vice President of Corporate Finance and interim CFO, Tom Cowhey, has been formally appointed the company's next CFO.
RTTNews | 317 दिनों पहले
CVS To Remove Some Cold, Cough Medicines With Phenylephrine

CVS To Remove Some Cold, Cough Medicines With Phenylephrine

CVS Health is removing certain over-the-counter or OTC cold and cough products with phenylephrine as the only active ingredient from its Pharmacy stores, reports said. The decision follows the U.S. Food and Drug Administration Advisory Committee's position on oral phenylephrine or PE.
RTTNews | 393 दिनों पहले
उपकरण
आर्थिक कैलेंडर
Market Hours
Interest Rates
Holidays Calendar
फोरेक्स मार्केट
फोरेक्स वॉलटीलिटी (अस्थिरता)
फोरेक्स कोरीलैशन
फोरेक्स के समाचार
forex analysis
सीओटी डाटा
लिक्विडिटी
फॉरेक्स कैल्कुलेटर
फोरेक्स के हीट का नक्शा
Indicators Heatmap
कम्युनिटी
कम्युनिटी
सिस्टमों
सर्व प्रसिद्ध सिस्टमों
रणनीतियां
प्रतियोगिता
फोरेक्स चार्टों
फोरेक्स भावना
आउटलुक इंडिकेटर
रीव्यूज़
ब्रोकरों
Prop Trading Firms
वी पी एस की सेवाएं
सिगनल को उपलब्ध कराने वाले
EA प्रोग्रामिंग की सेवाएं
Affiliate Programs
PAMM ब्रोकर की सेवाएं
रीबैट कार्यक्रम की सेवाएं
ट्रेडिंग के प्लैटफॉर्म
माहिर सलाहकारों
क्रिप्टो एक्सचेंज
Trading Courses
ब्रोकरों
फोरेक्स स्प्रेड
फोरेक्स ब्रोकर के क्वोट-चिह्न.
फोरेक्स ब्रोकरों के स्वाप
फोरेक्स ब्रोकर वॉल्यूम
फोरेक्स ब्रोकर की पदोन्नति Broker News
प्लेटफॉर्म
विजेट
विशेषताएं
API
RSS
Stock Portfolio
Affiliate Software
एडवांस चार्ट
सहयोग
अधिकतम पूछे जाने वाले प्रश्न (एफएक्यू )
सहायता
हमसे संपर्क करें
बग को रिपोर्ट करें!
बारे में
ब्लॉग
&प्रतिलिपि; 2024 Myfxbook Ltd. सर्वाधिकार सुरक्षित.
उच्च जोखिम चेतावनी: फॉरन एक्सचेंज ट्रेडिंग में उच्च स्तर का खतरा होता है जो हर निवेशकों के लिए सही नहीं हो सकता. लीवरेज अधिकतम खातर और हानि के अनावरण को उत्पन्न करता है. इससे पहले कि आप निर्णय लें फॉरन एक्सचेंज में ट्रेड करने का, ध्यान अपने निवेश के उद्देश्यों, अनुभव स्तर, और खतरा उठाने की सहिष्णुता पर विचार करें. आप कुछ या अपनी प्रारंभिक निवेश को खो सकते हैं. बिल्कुल भी उस पैसे को निवेश ना करें जो आप खोने को बर्दाश्त नहीं कर सकते. अपने आप को शिक्षित करें उन खतरों से जो फॉरन एक्सचेंज ट्रेडिंग से संबंधित हैं, और सलाह लें किसी स्वतंत्र आर्थिक या कर सलाहकार से अगर आपके पास कोई भी प्रश्न हैं तो. कोई भी डाटा या जानकारों जो दी जाती है वे केवल सूचनात्मक उद्देश्यों के लिए है, और यब ट्रेडिंग आशय या सलाह पर नियत नहीं है. पिछले निष्पादन भविष्य के परिणामों के लिए परियाचक नहीं हैं.